DexCom Cash on Hand 2010-2024 | DXCM
DexCom cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- DexCom cash on hand for the quarter ending September 30, 2024 was $2.492B, a 23.08% decline year-over-year.
- DexCom cash on hand for 2023 was $2.724B, a 10.91% increase from 2022.
- DexCom cash on hand for 2022 was $2.456B, a 10.07% decline from 2021.
- DexCom cash on hand for 2021 was $2.731B, a 0.87% increase from 2020.
| DexCom Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $2,724 |
| 2022 | $2,456 |
| 2021 | $2,731 |
| 2020 | $2,708 |
| 2019 | $1,533 |
| 2018 | $1,386 |
| 2017 | $549 |
| 2016 | $124 |
| 2015 | $115 |
| 2014 | $84 |
| 2013 | $55 |
| 2012 | $49 |
| 2011 | $82 |
| 2010 | $48 |
| 2009 | $28 |
| DexCom Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2,492 |
| 2024-06-30 | $3,121 |
| 2024-03-31 | $2,897 |
| 2023-12-31 | $2,724 |
| 2023-09-30 | $3,240 |
| 2023-06-30 | $3,636 |
| 2023-03-31 | $2,567 |
| 2022-12-31 | $2,456 |
| 2022-09-30 | $2,372 |
| 2022-06-30 | $2,755 |
| 2022-03-31 | $2,688 |
| 2021-12-31 | $2,731 |
| 2021-09-30 | $2,698 |
| 2021-06-30 | $2,585 |
| 2021-03-31 | $2,633 |
| 2020-12-31 | $2,708 |
| 2020-09-30 | $2,604 |
| 2020-06-30 | $2,509 |
| 2020-03-31 | $1,511 |
| 2019-12-31 | $1,533 |
| 2019-09-30 | $1,430 |
| 2019-06-30 | $1,378 |
| 2019-03-31 | $1,358 |
| 2018-12-31 | $1,386 |
| 2018-09-30 | $669 |
| 2018-06-30 | $606 |
| 2018-03-31 | $534 |
| 2017-12-31 | $549 |
| 2017-09-30 | $526 |
| 2017-06-30 | $497 |
| 2017-03-31 | $181 |
| 2016-12-31 | $124 |
| 2016-09-30 | $127 |
| 2016-06-30 | $116 |
| 2016-03-31 | $107 |
| 2015-12-31 | $115 |
| 2015-09-30 | $113 |
| 2015-06-30 | $98 |
| 2015-03-31 | $84 |
| 2014-12-31 | $84 |
| 2014-09-30 | $75 |
| 2014-06-30 | $61 |
| 2014-03-31 | $57 |
| 2013-12-31 | $55 |
| 2013-09-30 | $48 |
| 2013-06-30 | $46 |
| 2013-03-31 | $45 |
| 2012-12-31 | $49 |
| 2012-09-30 | $53 |
| 2012-06-30 | $61 |
| 2012-03-31 | $70 |
| 2011-12-31 | $82 |
| 2011-09-30 | $97 |
| 2011-06-30 | $106 |
| 2011-03-31 | $39 |
| 2010-12-31 | $48 |
| 2010-09-30 | $32 |
| 2010-06-30 | $40 |
| 2010-03-31 | $50 |
| 2009-12-31 | $28 |
| 2009-09-30 | $38 |
| 2009-06-30 | $49 |
| 2009-03-31 | $61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.759B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |